PellePharm
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
101 Mission St Ste 1950, San Francisco, ...Phone Number
(510) 502-6144Website
www.pellepharm.comRevenue
$16.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About PellePharm
PellePharm is a biotechnology company dedicated to addressing rare dermatological diseases, particularly Gorlin Syndrome and Basal Cell Carcinomas, through precision medicine. The company focuses on developing patidegib, an investigational topical treatment aimed at reducing tumor burden in affected patients. Collaborating with organizations like the Gorlin Syndrome Alliance, PellePharm strives to advance research and transform the lives of individuals impacted by these conditions. With a commitment to patient care, PellePharm is working towards providing effective therapies in a field with currently no FDA-approved options.Explore more
PellePharm Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PellePharm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if PellePharm had a recent Job posting/layoffs
Check if PellePharm has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at PellePharm
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once PellePharm has new funding data
Earning: See what the market has to say on PellePharm recently announced quarterly report
Check out if PellePharm is spiking on competitors!
PellePharm, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when PellePharm launches new products
Recommended Actions
Reach out to Masked Content who joined PellePharm as Masked Content
Find 3 more new buyers
Compare Similar Companies to PellePharm
Compare insights from companies similar to PellePharm, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PellePharm is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
PellePharm is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about PellePharm.
PellePharm financials insights
Gather financial insights about PellePharm, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Private Equity
$1.3M
2015
Private Equity
$4.5M
Private Equity
$719K
2016
Private Equity
$3.2M
2017
Series B
$20M
2018
Unspecified
$70M
PellePharm Tech Stack
A closer look at the technologies used by PellePharm
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PellePharm
Sign Up For FreeTo access detailed company insights
PellePharm is a biotechnology company dedicated to addressing rare dermatological diseases, particularly Gorlin Syndrome and Basal Cell Carcinomas, through precision medicine. The company focuses on developing patidegib, an investigational topical treatment aimed at reducing tumor burden in affected patients. Collaborating with organizations like t... Read More
